InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,771.81
(
1.16%
)
US TECH 100
19,568.00
(
1.11%
)
Dow Jones
42,275.91
(
1.23%
)
Brent Oil
73.51
(
-0.68%
)
Bitcoin
71,501.33
(
1.84%
)
Post# of 253507
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120654
Boards Moderated 13
Alias Born 09/05/2002

DewDiligence

Member Level

Re: AlpineBV_Miller post# 33554

Tuesday, 09/05/2006 2:49:42 PM

Tuesday, September 05, 2006 2:49:42 PM

Post# of 253507
> NBIX – Finally, does this ring false to anyone else? PFE punts the drug for want of a food-based PK/PD trial? Very strange.<

PFE pulled out because of the separate non-approvable letter for sustained-release Indiplon, calculating that immediate-release Indiplon was not a sufficiently differentiated product to bother with. Today’s NBIX news does not have any bearing on the wisdom of PFE’s move.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up